Johnson & Johnson (JNJ)

NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals · US

$238.95
3.31% today
Pharma MajorsDividend Aristocrats

Should you buy JNJ?

Bullish

Johnson & Johnson is up 3.3% today. Recent news highlights growth acceleration and technological innovation, supporting the upward move.

  • Notable 3.3% daily move
  • News: growth acceleration
  • News: technological innovation

This is educational analysis, not investment advice. Past performance doesn't predict future results.

Market Cap

$556.77B

52W High

$239.03

52W Low

$234.04

Industry

Pharmaceuticals

Understand the fundamentals

Plain-English rules of thumb for beginners — tap the  to learn each one. Not investment advice.

P/E — Price / Earnings
26.9xAverage

How many years of profit you're paying for. Lower can mean cheaper — but a very low number can also signal trouble.

Around the market average.

P/B — Price / Book
7.2xTake a closer look

Price vs the company's net assets (book value). Under 1x means it trades below what it owns on paper.

High — you're paying a big premium over assets.

ROE — Return on Equity
26.3%Looks healthy

How efficiently the company turns shareholders' money into profit. Higher is better.

Strong — uses your capital efficiently.

Net Margin
21.8%Looks healthy

Of every $100 in sales, how much becomes actual profit. Higher = more profitable business.

Highly profitable per dollar of sales.

Dividend Yield
2.32%Info

Annual cash the company pays you, as a % of the share price. Not better or worse — just a different kind of return.

Pays you cash while you hold.

These signals are simple, sector-agnostic rules of thumb (a “good” P/E for a bank differs from a tech firm). Use them to learn what to look at — not as buy/sell calls.

Recent news

Think you can trade JNJ better?

Practice with real prices and $10,000 of paper money. An AI coach grades every trade so you learn before risking real cash.

Start free — no signup pressure